REGENERON PHARMACEUTICALS, INC.
Q4 2024 13F Holdings
- Locationtarrytown, NY
- Num holdings
6
- Value ($000)
$1,094,640
- Date Filed02/07/2025
- Form type13F-HR
- CIK0000872589
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | COMMON STOCK | 02043Q107 | $1.05B | 96 % | 4,444,445 | ||
NTLA Intellia Therapeutics, Inc. | COMMON STOCK | 45826J105 | $43.18M | 4 % | 3,702,995 | ||
TSVT 2seventy bio, Inc. | COMMON STOCK | 901384107 | $3.69M | 0 % | 1,254,827 | ||
ACET Adicet Bio, Inc. | COMMON STOCK | 007002108 | $931.39K | 0 % | 968,183 | ||
ADVM Adverum Biotechnologies, Inc. | COMMON STOCK | 00773U207 | $844.85K | 0 % | 180,909 | ||
bluebird bio, Inc. | COMMON STOCK | 09609G209 | $175.14K | 0 % | 21,000 |
Rows Per Page
1 - 6 of 610
- 10
- 50
- 100